Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript

And then, there was a rather significant review publication that came out right around the time of the start of the meeting, and it was written by many, many preeminent scientists and researchers who really set the tone for that entire community. And this is an extensive publication that covers not only optical genome mapping, of course, but all of the different methods. And when you look at publications like that, they’re starting to spell out algorithms that discuss the use of optical genome mapping alongside all the other tools. So, the reason that, that kind of advancement is so incredibly important is that when Bionano commercial teams goes to a lab and says, “Hi, I’m here to talk to you about optical genome mapping,” a year ago the question that they would get is, “Where does optical genome mapping fit in my lab and what should I do with it?” But now after all these publications, they understand the answers to those questions before we meet them.

It’s a huge leap forward for us. So, thanks for giving me a chance to talk about it.

Unidentified Analyst: Thank you. That’s very encouraging. Thanks for taking my questions.

Operator: Thank you, and there are no further questions at this time. I would now like to turn the conference back to Erik Holmlin, CEO, for closing remarks.

Erik Holmlin: Thanks, Kyle. I appreciate everyone joining here today. We’re excited to finish out this fourth quarter and then share with you the results after the end of the year and our full year call. So, thank you very much for joining today.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.